Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott: This Dividend King Is Ready For Takeoff
02:58am, Monday, 31'st Jul 2023
Healthcare investing provides opportunities with wide moats and long-term potential in companies like Abbott Laboratories. ABT's four major segments, including Medical Devices and Diagnostic Products,
Magnetar Financial LLC Reduces Stake in MedTech Acquisition Corp
08:32pm, Thursday, 27'th Jul 2023
On July 25, 2023, Magnetar Financial LLC (Trades, Portfolio), a renowned investment firm, reduced its stake in MedTech Acquisition Corp ( MTACU , Financial). This article provides an in-depth analysis
3 Ultrareliable Dividend Stocks to Buy and Hold for Decades
10:37am, Monday, 24'th Jul 2023
Now that Johnson & Johnson no longer sells consumer goods, it's poised to grow, along with sales of pharmaceuticals and medical technology. Medtronic's dominance in the medical device industry has all
Abbott Laboratories 2Q profit tops expectations driven by strong medical devices sales
01:08pm, Thursday, 20'th Jul 2023
Abbott Laboratories (NYSE:ABT) shares surged on Thursday after the company posted a second-quarter earnings beat driven by strong demand for its medical devices as surgery volumes increase. Its adjust
Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript
12:59pm, Thursday, 20'th Jul 2023
Abbott Laboratories (NYSE:ABT ) Q2 2023 Earnings Conference Call July 20, 2023 9:30 AM ET Company Participants Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief Execut
Abbott (ABT) Q2 Earnings & Revenues Beat Estimates, Down Y/Y
12:09pm, Thursday, 20'th Jul 2023
Abbott Laboratories ABT reported second-quarter 2023 adjusted earnings of $1.08 per share, which topped the Zacks Consensus Estimate by 3.8%. However, the adjusted figure declined from the prior-year
Stock movers July 20, 2022: Johnson & Johnson, Kenvue, and Abbott Labs
11:38am, Thursday, 20'th Jul 2023
Johnson & Johnson, Kenvue, and Abbott Labs posted second quarter results that topped analyst estimates. Yahoo Finance Live anchors break down the market reaction to the report.
Abbott Laboratories Has the Prescription for Higher Share Prices
10:45am, Thursday, 20'th Jul 2023
Abbott Laboratories NYSE: ABT is a tale of two stories. The first is its recovery from the COVID-19 boost and bubble.
Abbott (ABT) Q2 Earnings and Revenues Surpass Estimates
09:54am, Thursday, 20'th Jul 2023
Abbott (ABT) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.43 per share a year ago.
Abbott Labs' stock up 1.6% premarket after earnings fall but still top analyst estimates
07:42am, Thursday, 20'th Jul 2023
Abbott Laboratories' stock ABT, +0.31% rose 1.6% in premarket trade Thursday, after the diagnostics and medical-device company posted earnings that were lower than a year ago but ahead of analyst esti
Abbott beats quarterly profit estimates on demand for medical devices
07:32am, Thursday, 20'th Jul 2023
Abbott Laboratories on Thursday reported second-quarter profit above expectations, due to recovery in surgical procedure volumes and demand for its diabetes care devices.
Our Dividend Growth Portfolio Continues To Outpace The S&P 500
10:56pm, Wednesday, 19'th Jul 2023
In 2015, I purchased 15 of the largest cap U.S. dividend achievers, which have continued to outpace the S&P 500. The portfolio was designed to provide greater protection during recessions and severe b
2 Medical Stocks to Buy as Earnings Approach
07:35pm, Tuesday, 18'th Jul 2023
Among the broader healthcare space, Abbott Laboratories (ABT) and Intuitive Surgical (ISRG) are two medical stocks that will highlight this week's earnings lineup.
10 Dividend Growth Stocks For July 2023
09:00am, Saturday, 15'th Jul 2023
The article presents a monthly series of 10 top-ranked dividend growth stocks for further research and potential investment. The stocks are ranked based on quality scores, with tie-breaking metrics in
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:24am, Friday, 14'th Jul 2023
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
